A detailed history of West Michigan Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, West Michigan Advisors, LLC holds 9,044 shares of ABBV stock, worth $1.63 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
9,044
Previous 10,028 9.81%
Holding current value
$1.63 Million
Previous $1.72 Million 3.84%
% of portfolio
0.6%
Previous 0.57%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$163.84 - $199.33 $161,218 - $196,140
-984 Reduced 9.81%
9,044 $1.79 Million
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $13,466 - $15,726
87 Added 0.88%
10,028 $1.72 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $65,686 - $74,843
411 Added 4.31%
9,941 $1.81 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $20,227 - $22,780
147 Added 1.57%
9,530 $1.48 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $15,362 - $17,784
115 Added 1.24%
9,383 $1.4 Million
Q2 2023

Aug 15, 2023

SELL
$132.51 - $164.9 $81,493 - $101,413
-615 Reduced 6.22%
9,268 $1.25 Million
Q1 2023

Apr 21, 2023

BUY
$144.61 - $166.54 $697,309 - $803,055
4,822 Added 95.28%
9,883 $1.58 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $10,096 - $12,108
-73 Reduced 1.42%
5,061 $818,000
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $11,273 - $12,930
84 Added 1.66%
5,134 $690,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $550 - $699
4 Added 0.08%
5,050 $773,000
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $93,969 - $116,590
712 Added 16.43%
5,046 $818,000
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $465,601 - $589,120
4,334 New
4,334 $587,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track West Michigan Advisors, LLC Portfolio

Follow West Michigan Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Michigan Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Michigan Advisors, LLC with notifications on news.